Art

J-GLOBAL ID：201502236172312732   Reference number：15A0566540

A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI)

食道の転移性扁平上皮癌におけるネダプラチンと5-フルオロウラシルの第2相試験:日本臨床腫瘍研究グループ(JCOG)試験(JCOG 9905-DI)

Author (10)： KATO Ken (National Cancer Center Hospital, Tokyo, JPN) ,  MURO Kei (National Cancer Center Hospital, Tokyo, JPN) ,  MURO Kei (Aichi Cancer Center Hospital, Aichi, JPN) ,  ANDO Nobutoshi (Tokyo Dental Coll., Chiba, JPN) ,  NISHIMAKI Tadashi (Ryukyu Univ. Hospital, Okinawa, JPN) ,  OHTSU Atsushi (National Cancer Center Hospital East, Chiba, JPN) ,  AOGI Kenjiro (National Hospital Organization Shikoku Cancer Center, Ehime, JPN) ,  AOYAMA Norio (Kanagawa Cancer Center Hospital, Kanagawa, JPN) ,  NAGAI Kagami (Tokyo Medical and Dental Univ. School of Medicine, Tokyo, JPN) ,  KATO Hoichi (National Cancer Center Hospital, Tokyo, JPN)
Material： Esophagus (Web)
Volume： 11  Issue： 3  Page： 183-188 (WEB ONLY)  Publication year： Jul. 2014 
JST Material Number： U0600A  ISSN： 1612-9059  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *squamous cell carcinoma ,...
Semi thesaurus term： *Squamous cell carcinoma of oesophagus ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0566540&from=J-GLOBAL&jstjournalNo=U0600A") }}

JST classification (3)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Fluorouracil

Reference (28)：

• Cancer Statistics in Japan 2007.
• Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: A Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992;22:172-6.
• Hayashi K, Ando N, Watanabe H, et al. Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407). Jpn J Clin Oncol. 2001;31:419-23.
• Grünberger B, Raderer M, Schmidinger M, et al. Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res. 2007;27:2705-14.
• Suzumura Y, Kato T, Ueda R, et al. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedi-chloroplatinum(II). Anticancer Res. 1989;9:1083-8.

Terms in the title (9)： 食道 ,  転移性扁平上皮癌 ,  ネダプラチン ,  5-フルオロウラシル ,  第2相試験 ,  日本臨床腫瘍研究グループ ,  JCOG ,  試験 ,  DI